COMMD2 and metastatic malignant neoplasm in the lymph nodes: Clinical association analyses demonstrated that increased COMMD2 expression was correlated with higher histological grade, more advanced clinical stage, lymph node metastasis and the TP53 mutation status in LIHC patients.